Surrozen, Inc. (SRZN)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
SRZN Insider Trading Activity
SRZN Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $6,049,986 | 4 | 67 |
Sells | $35,157 | 2 | 33 |
Related Transactions
| COLUMN GROUP III GP, LP | 10 percent owner | 1 | $3M | 0 | $0 | $3M |
| Kutzkey Tim | 1 | $3M | 0 | $0 | $3M | |
| Parker Craig C | Chief Executive Officer | 1 | $24,999 | 0 | $0 | $24,999 |
| Williams Charles O | CFO and COO | 1 | $24,999 | 1 | $20,514 | $4,485 |
| Li Yang | Exec. Vice President, Research | 0 | $0 | 1 | $14,643 | $-14,643 |
About Surrozen, Inc.
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody …
Insider Activity of Surrozen, Inc.
Over the last 12 months, insiders at Surrozen, Inc. have bought $6.05M and sold $35,157 worth of Surrozen, Inc. stock.
On average, over the past 5 years, insiders at Surrozen, Inc. have bought $3.02M and sold $19,540 worth of stock each year.
Highest buying activity among insiders over the last 12 months: COLUMN GROUP III GP, LP (10 percent owner) — $3M. Kutzkey Tim () — $3M. Parker Craig C (Chief Executive Officer) — $24,999.
The last purchase of 193,548 shares for transaction amount of $3M was made by Kutzkey Tim () on 2024‑04‑04.
List of Insider Buy and Sell Transactions, Surrozen, Inc.
| 2025-01-03 | Sale | Li Yang | Exec. Vice President, Research | 843 0.0276% | $17.37 | $14,643 | -32.56% | |
| 2025-01-03 | Sale | Williams Charles O | CFO and COO | 1,181 0.0387% | $17.37 | $20,514 | -32.56% | |
| 2024-04-04 | Kutzkey Tim | 193,548 7.5667% | $15.50 | $3M | -9.62% | |||
| 2024-04-04 | COLUMN GROUP III GP, LP | 10 percent owner | 193,548 7.5667% | $15.50 | $3M | -9.62% | ||
| 2024-04-04 | Williams Charles O | CFO and COO | 1,474 0.0631% | $16.96 | $24,999 | -9.62% | ||
| 2024-04-04 | Parker Craig C | Chief Executive Officer | 1,474 0.0631% | $16.96 | $24,999 | -9.62% | ||
| 2020-12-01 | Soffer Benny | director | 24,000 – | $0 | $0 | +1114.75% | ||
| 2020-12-01 | Livingston Kevin Harold | Chief Financial Officer | 24,000 – | $0 | $0 | +1114.75% | ||
| 2020-12-01 | Consonance Life Sciences | director | 24,000 – | $0 | $0 | +1114.75% | ||
| 2020-12-01 | BLUTT MITCHELL J MD | director | 24,000 – | $0 | $0 | +1114.75% | ||
| 2020-11-23 | Consonance Capman GP, LLC | director | 1M – | $0 | $0 | +1115.00% | ||
| 2020-11-23 | Soffer Benny | director | 410,000 – | $0 | $0 | +1115.00% | ||
| 2020-11-23 | Livingston Kevin Harold | Chief Financial Officer | 410,000 – | $0 | $0 | +1115.00% | ||
| 2020-11-23 | Consonance Life Sciences | director | 410,000 – | $0 | $0 | +1115.00% | ||
| 2020-11-23 | BLUTT MITCHELL J MD | director | 410,000 – | $0 | $0 | +1115.00% | ||
| 2020-11-18 | Sale | Soffer Benny | director | 90,000 0.0025% | $0.01 | $981 | +1115.66% | |
| 2020-11-18 | Sale | Livingston Kevin Harold | Chief Financial Officer | 90,000 0.0025% | $0.01 | $981 | +1115.66% | |
| 2020-11-18 | Sale | Consonance Life Sciences | director | 90,000 0.0025% | $0.01 | $981 | +1115.66% | |
| 2020-11-18 | Sale | BLUTT MITCHELL J MD | director | 90,000 0.0025% | $0.01 | $981 | +1115.66% |
SRZN Institutional Investors: Active Positions
| Increased Positions | 9 | +33.33% | 471,135 | +21.63% |
| Decreased Positions | 8 | -29.63% | 115,367 | -5.3% |
| New Positions | 4 | New | 262,797 | New |
| Sold Out Positions | 3 | Sold Out | 40,954 | Sold Out |
| Total Postitions | 28 | +3.7% | 3M | +16.33% |
SRZN Ownership Change vs Market
Institutional Investor Ownership
| Column Group Llc | $9,389.00 | 27% | 810,088 | 0 | 0% | 2024-12-31 |
| Stempoint Capital Lp | $4,063.00 | 11.69% | 350,573 | +167,655 | +91.66% | 2024-12-31 |
| Ra Capital Management, L.P. | $3,275.00 | 9.42% | 282,580 | 0 | 0% | 2024-12-31 |
| Nantahala Capital Management, Llc | $2,272.00 | 6.53% | 196,023 | +8,817 | +4.71% | 2024-12-31 |
| Stonepine Capital Management, Llc | $1,590.00 | 4.57% | 137,200 | +27,200 | +24.73% | 2024-12-31 |
| Regents Of The University Of California | $1,544.00 | 4.44% | 133,207 | +133,207 | New | 2024-12-31 |
| Euclidean Capital Llc | $1,016.00 | 2.92% | 87,696 | 0 | 0% | 2024-12-31 |
| Armistice Capital, Llc | $877.00 | 2.52% | 75,694 | -63,306 | -45.54% | 2024-12-31 |
| Vanguard Group Inc | $755.00 | 2.17% | 65,135 | 0 | 0% | 2024-12-31 |
| Cvi Holdings, Llc | $752.00 | 2.16% | 64,905 | +64,905 | New | 2024-06-30 |